Fzata

Fzata is a private platform biopharmaceutical company. The company owns two proprietary platforms: one for generating fully humanized multispecific antibodies, and the other, BioPYM, for localized delivery of live recombinant yeast therapeutics to treat gastrointestinal-related diseases and conditions.